Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites
Future Oncology, Volume 9, No. 3, Year 2013
Notification
URL copied to clipboard!
Description
Aim: To evaluate tumor response in patients with hypovascular liver metastases from the most common primary sites treated with chemoembolization. Materials & methods: Chemoembolization was performed in 190 patients (five groups) who had hypovascular liver metastases from the colon (n = 66), breast (n = 40), uveal malignant melanoma (n = 20), pancreas (n = 48) and stomach (n = 16). Surgical resection of primary sites had been performed for all included patients. Tumor response, survival statistics from the first chemoembolization using Kaplan-Meier method and progression rate of embolized lesions were evaluated by analysis of variance with Tukey's post hoc test. Results: Multiple comparison between the groups showed no statistical significant difference in local tumor response (H: 9.23; p > 0.05). Survival indices of the patients, including survival rate, progression-free survival rate, median survival time and time to progression, demonstrated significant difference between the groups during the follow-up period (H: 9.7; p = 0.045). The progression rate of treated liver metastases from colon, breast, uvea, pancreas and stomach were 16.6, 17.5, 30.0, 25.0 and 32.0%, respectively (p = 0.002). Conclusion: Hypovascular liver metastases treated with chemoembolization may demonstrate equal local response, but are significantly different in rate of progression and survival. © 2013 Future Medicine Ltd.
Authors & Co-Authors
Farshid, Parviz
Germany, Osnabruck
Marienhospital Osnabrück
Darvishi, Abbas
Germany, Frankfurt am Main
Universitätsklinikum Frankfurt
Naguib, Nagy Naeem
Germany, Frankfurt am Main
Universitätsklinikum Frankfurt
Bazrafshan, Babak
Germany, Frankfurt am Main
Universitätsklinikum Frankfurt
Paul, Jijo
Germany, Frankfurt am Main
Universitätsklinikum Frankfurt
Mbalisike, Emmanuel C.
Germany, Frankfurt am Main
Universitätsklinikum Frankfurt
Vogl, Thomas Josef
Germany, Frankfurt am Main
Universitätsklinikum Frankfurt
Statistics
Citations: 8
Authors: 7
Affiliations: 2
Identifiers
Doi:
10.2217/fon.12.191
ISSN:
17448301
Research Areas
Cancer
Health System And Policy
Study Design
Cohort Study